Lido Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,290
Closed -$327K 697
2019
Q3
$327K Sell
3,290
-129
-4% -$12.3K 0.02% 427
2019
Q2
$316K Sell
3,419
-6,826
-67% -$648K 0.02% 414
2019
Q1
$966K Sell
10,245
-5,011
-33% -$438K 0.06% 186
2018
Q4
$977K Buy
15,256
+609
+4% +$45K 0.1% 131
2018
Q3
$1.31M Buy
14,647
+9,736
+198% +$860K 0.13% 100
2018
Q2
$390K Buy
4,911
+479
+11% +$39.8K 0.04% 256
2018
Q1
$395K Buy
+4,432
New +$425K 0.05% 232
2017
Q3
Sell
-1,549
Closed -$201K 347
2017
Q2
$201K Buy
+1,549
New +$190K 0.04% 248

Other funds holding CELG

Lido Advisors's CELG Position: Q4 2019 in Review

Lido Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,290 shares — an estimated $327K sold.

Lido Advisors first reported a position in CELG in Q2 2017 and held it in 8 quarters. The position peaked at $1.31M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Lido Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Lido Advisors sold 3,290 Celgene Corp shares in Q4 2019, an estimated $327K.
  • Lido Advisors first reported a position in Celgene Corp in Q2 2017 and held it in 8 quarters.
  • Lido Advisors's Celgene Corp position peaked at $1.31M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Lido Advisors's 13F filing for Q4 2019, filed 7 Feb 2020.